Increased oxidative stress in patients with depression and its relationship to treatment
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Oxidative stress may play a role in the pathogenesis of depression. We tested the hypothesis that urinary F2 isoprostane, a robust marker of oxidative stress, was increased in patients with depression and associated with symptoms and response to treatment. Urinary F2 isoprostane was compared in 18 patients with depression and 36 age and sex matched control subjects. In patients, we tested the association between oxidative stress, depression questionnaires and antidepressant treatment. Urinary F2 isoprostane excretion was significantly higher in patients with depression than in control subjects. This association remained significant after adjustment for age, sex and BMI. Depression symptom severity scores were not correlated with F2 isoprostane excretion. Nine patients were treated with sertraline or bupropion for eight weeks. Depression severity rating scale scores decreased significantly and F2 isoprostane excretion increased. The increase in F2 isoprostane excretion was inversely correlated with the improvement in Hamilton Depression Rating 17 items. In conclusion, oxidative stress is increased in patients with depression. However, although treatment with either bupropion or sertraline reduces the symptoms of depression, it may increase F2 isoprostane excretion. These results suggest that alternative mechanisms, beyond oxidative stress, may be involved in the development of depression and subsequent responses to treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069 · cited 2×
“In addition, oxidative stress has been postulated to have an important role in the pathogenesis of depression (Ng et al., 2008).”
Bilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718
Sarandol, A., Sarandol, E., Eker, S. S., Erdinc, S., Vatansever, E., & Kirli, S. (2007) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.829 · Cited by 486
Antioxidant enzyme activities and oxidative stress in affective disorders
Erkan Ozcan, M., Gulec, M., Ozerol, E., Polat, R., & Akyol, O. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200403000-00006 · Cited by 368 · cited 1×
“Because enzymatic function was decreased and MDA levels increased in patients with affective disorders, the authors concluded that the antioxidant system was impaired during mood episodes (Ozcan et al., 2004).”
Quantification of F2-isoprostanes as a biomarker of oxidative stress
Milne, G. L., Sanchez, S. C., Musiek, E. S., & Morrow, J. D. (2007) · Nature Protocols · doi:10.1038/nprot.2006.375 · Cited by 333
Self-citationGarland, S. N., Carlson, L. E., Cook, S., Lansdell, L., & Speca, M. (2007) · Supportive Care in Cancer · doi:10.1007/s00520-007-0280-5 · Cited by 266 · cited 2×
“sion) (Garland et al., 2007).”
Cumurcu, B. E., Ozyurt, H., Etikan, I., Demir, S., & Karlidag, R. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02004.x · Cited by 165 · cited 1×
“Others have used different techniques, such as lower total oxidant capacity and higher total oxidant status in patients with major depression (Cumurcu et al., 2009).”
Kotan, V. O., Sarandol, E., Kirhan, E., Ozkaya, G., & Kirli, S. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.021 · Cited by 149 · cited 1×
“Subsequently, other studies have shown decreases in markers of oxidative stress following antidepressant treatment (Bilici et al., 2001; Kotan et al., 2011).”
Depression and oxidative damage to lipids
Yager, S., Forlenza, M. J., & Miller, G. E. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.010 · Cited by 120 · cited 1×
“A recent study demonstrated that patients with depression had higher serum concentrations of F2 isoprostanes (Yager et al., 2010).”
Cited by
Is depression associated with increased oxidative stress? A systematic review and meta-analysis
Black, C. N., Bot, M., Scheffer, P. G., Cuijpers, P., & Penninx, B. W. J. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.025 · Cited by 711
Oxidative Stress and Psychological Disorders
Salim, S. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120230309 · Cited by 557
Goldstein, B. I., Carnethon, M. R., Matthews, K. A., McIntyre, R. S., Miller, G. E., Raghuveer, G., Stoney, C. M., Wasiak, H., & McCrindle, B. W. (2015) · Circulation · doi:10.1161/cir.0000000000000229 · Cited by 519
Immune mechanisms linked to depression via oxidative stress and neuroprogression
Bakunina, N., Pariante, C. M., & Zunszain, P. A. (2015) · Immunology · doi:10.1111/imm.12443 · Cited by 444
Lopresti, A. L., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.017 · Cited by 371
“Isoprostanes – levels of isoprostanes are elevated in patients suffering from depression as demonstrated by higher urinary concentrations of 8-iso-PGF2α (Chung et al., 2013, Milaneschi et al., 2013), and a β-oxidation metabolite of 8-iso-PGF2α, 2,3-dinor-5,6-dihydro-15-F2t-isoprostane (F2-isoPM).”
BackgroundCzarny, P., Wigner, P., Galecki, P., & Sliwinski, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.036 · Cited by 310
“Yet, an alternative marker of oxidative damage to fatty acids, i.e. 8-iso-prostaglandin F2α (8- iso-PGF2α), was also found to be elevated in DD [Dimopoulos et al. 2008, Yager et al. 2010, Chung et al. 2013].”
BackgroundSmaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegaliński, E., Pera, J., & Filip, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.015 · Cited by 252
“In depressed patients, markers of lipid peroxidation were increased [5,6,11,14–18], especially during depressive episodes [3], while elevated levels of isoprostanes were present in urine [19,20], serum [21] and plasma [17].”
BackgroundJiménez-Fernández, S., Gurpegui, M., Díaz-Atienza, F., Pérez-Costillas, L., Gerstenberg, M., & Correll, C. U. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14r09179 · Cited by 217
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., & Broersen, K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190863 · Cited by 204
“Down’s syndrome [20], depression [21], and diabetes”
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
“Higher concentrations of F2-isoprostanes have been found in urine [202,203] and blood [204,205] of patients with MDD.”
BackgroundTalaei, A., Hassanpour Moghadam, M., Sajadi Tabassi, S. A., & Mohajeri, S. A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.035 · Cited by 165
“Some studies showed that oxidative stress was increased in depressed patients and reported the correlations between reduced oxidative stress and antidepressant treatment (Chung et al., 2013; Michel et al., 2012; Zhou et al., 2006).”
BackgroundA model of the mitochondrial basis of bipolar disorder
Morris, G., Walder, K., McGee, S. L., Dean, O. M., Tye, S. J., Maes, M., & Berk, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.014 · Cited by 162
Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103
“More than that, oxidative stress evaluation through F2-isoprostanes quantification [269] in depressed patients treated with sertraline or bupropion for eight months revealed high rates of oxidation, despite some psychiatric improvements [139].”
Background
Metadata
- Authors
- Chung, C. P., Schmidt, D., Stein, C. M., Morrow, J. D., & Salomon, R. M.
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 206
- Issue
- 2-3
- Pages
- 213-216
- ISSN
- 0165-1781 (ISSN-L)
- OpenAlex
- W2147524199
- Cited by
- 99
- References
- 13
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.